The In Silico World project, funded by the European Commission through the H2020 framework program, aims at accelerating the uptake of modelling and simulation technologies used for the development and regulatory assessment of medicines and medical devices (In Silico Trials), by lowering seven identified barriers: development, validation, accreditation, optimisation, exploitation, information, and training.

As part of this scope, we plan to make available in open access a number of resources that should help other organisations in lowering such barriers, and ultimately widening the adoption of In Silico Trials.

As they are released, such resources will be made available through Zenodo, within this Community.